Marshall Wace North America’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Marshall Wace North America’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-66,836	Closed	-$407K	–	1670
2019 Q2	$407K	Buy	+66,836	New	+$355K	﹤0.01%	929
2019 Q1	–	Sell	-2,389	Closed	-$32K	–	2069
2018 Q4	$32K	Buy	+2,389	New	+$40.3K	﹤0.01%	1354
2018 Q3	–	Sell	-304,956	Closed	-$7.79M	–	1577
2018 Q2	$7.79M	Sell	304,956 -385,648	-56%	-$8.99M	0.04%	395
2018 Q1	$13.9M	Buy	690,604 +558,417	+422%	+$13M	0.07%	324
2017 Q4	$2.65M	Buy	+132,187	New	+$2.6M	0.01%	763
2017 Q3	–	Sell	-62,324	Closed	-$935K	–	1627
2017 Q2	$935K	Buy	+62,324	New	+$1.04M	0.01%	953

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace North America's DPLO Position: Q3 2019 in Review

Marshall Wace North America sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2019, closing a stake of 66,836 shares — an estimated $407K sold.

Marshall Wace North America first reported a position in DPLO in Q2 2017 and held it in 6 quarters. The position peaked at $13.9M in Q1 2018. 137 funds tracked by Wall St. Rank hold DPLO as of Q3 2019.

Marshall Wace North America reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2019 after selling out during the quarter.
Marshall Wace North America sold 66,836 DIPLOMAT PHARMACY, INC. shares in Q3 2019, an estimated $407K.
Marshall Wace North America first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2017 and held it in 6 quarters.
Marshall Wace North America's DIPLOMAT PHARMACY, INC. position peaked at $13.9M in Q1 2018.
137 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2019.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.